Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hutchinson's Melanotic Freckle × Aminolevulinic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 30 Brain Neoplasms 21 Glioblastoma 19 Glioma 18 Carcinoma, Basal Cell 9 Skin Neoplasms 5 Precancerous Conditions 5 Astrocytoma 5 Gliosarcoma 4 Oligodendroglioma 3 Neoplasms 3 Carcinoma, Squamous Cell 3 Squamous Intraepithelial Lesions 2 Skull Base Neoplasms 2 Skin Diseases 2 Sarcoma 2 Pituitary Neoplasms 2 Mycosis Fungoides 2 Meningioma 2 Lymphoma, T-Cell, Cutaneous 2 Head and Neck Neoplasms 2 Central Nervous System Neoplasms 2 Basal Cell Nevus Syndrome 2 Urinary Bladder Neoplasms 1 The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1 Sezary Syndrome 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Nonmelanoma Skin Cancers 1 Neurofibromatosis 1 1

Interventions

Imiquimod 3 Radiotherapy 1 Intravital Microscopy 1 Equipment and Supplies 1 BF-200 ALA 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685592 2018-05-30

LM PDT

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed

Hutchinson's Melanotic Freckle

Data powered by HemOnc (CC BY 4.0) Colophon ⚡